Stock Analysis
CSPC Innovation Pharmaceutical First Quarter 2024 Earnings: EPS: CN¥0.056 (vs CN¥0.095 in 1Q 2023)
CSPC Innovation Pharmaceutical (SZSE:300765) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥524.1m (down 27% from 1Q 2023).
- Net income: CN¥79.1m (down 39% from 1Q 2023).
- Profit margin: 15% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue.
- EPS: CN¥0.056 (down from CN¥0.095 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
CSPC Innovation Pharmaceutical Earnings Insights
Looking ahead, revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Pharmaceuticals industry in China.
Performance of the Chinese Pharmaceuticals industry.
The company's shares are up 9.9% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with CSPC Innovation Pharmaceutical (including 1 which is concerning).
Valuation is complex, but we're helping make it simple.
Find out whether CSPC Innovation Pharmaceutical is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300765
CSPC Innovation Pharmaceutical
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally.
Flawless balance sheet with high growth potential.